Plant ID: NPO17801
Plant Latin Name: Drimia altissima
Taxonomy Genus: Drimia
Taxonomy Family: Hyacinthaceae
NCBI TaxonomyDB:
65774
Plant-of-the-World-Online:
534485-1
Mauritania; Sudan; Guinea; Ethiopia; Rwanda; Somalia; Swaziland; Nigeria; Cameroon; Cote d'Ivoire; Kenya; Benin; Ghana; Senegal; Malawi; Togo; Sierra Leone; Eritrea; Gambia; Tanzania; Gabon; Guinea-Bissau; Mali; Angola; Chad; South Africa; Burkina Faso; Djibouti; Congo; Uganda; Namibia; Niger; Botswana
ADA; | |
BCL2; | |
TERT; | |
MAPK1; | |
SLCO1B3; SLCO1B1; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Hydrolase | ADA | Adenosine deaminase | P00813 | CHEMBL1910 |
Miscellaneous ion channel | BCL2 | Apoptosis regulator Bcl-2 | P10415 | CHEMBL4860 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0010035; response to inorganic substance | 1.068E-05 | 9.075E-02 | ADA, BCL2, MAPK1, TERT |
BP | GO:0050896; response to stimulus | GO:0000302; response to reactive oxygen species | 2.449E-05 | 9.075E-02 | ADA, BCL2, MAPK1 |
BP | GO:0032502; developmental process | GO:0014031; mesenchymal cell development | 4.236E-05 | 9.075E-02 | BCL2, MAPK1 |
BP | GO:0051179; localization | GO:0043252; sodium-independent organic anion transport | 4.236E-05 | 9.075E-02 | SLCO1B1, SLCO1B3 |
BP | GO:0051179; localization | GO:0015721; bile acid and bile salt transport | 4.873E-05 | 9.075E-02 | SLCO1B1, SLCO1B3 |
BP | GO:0032502; developmental process | GO:0007568; aging | 5.703E-05 | 9.075E-02 | ADA, BCL2, TERT |
BP | GO:0009987; cellular process | GO:2001240; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 6.281E-05 | 9.075E-02 | BCL2, TERT |
BP | GO:0050896; response to stimulus | GO:0035094; response to nicotine | 9.169E-05 | 9.075E-02 | BCL2, MAPK1 |
CC | GO:0044464; cell part | GO:0032839; dendrite cytoplasm | 3.364E-05 | 9.075E-02 | ADA, MAPK1 |
MF | GO:0005215; transporter activity | GO:0015125; bile acid transmembrane transporter activity | 1.718E-05 | 9.075E-02 | SLCO1B1, SLCO1B3 |
MF | GO:0005215; transporter activity | GO:0015347; sodium-independent organic anion transmembrane transporter activity | 3.095E-05 | 9.075E-02 | SLCO1B1, SLCO1B3 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 2.461E-04 | 1.164E-01 | ADA, MAPK1 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.876E-03 | 2.245E-01 | SLCO1B1, SLCO1B3 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.485E-06 | 1.545E-04 | SLCO1B1, SLCO1B3, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 1.966E-04 | 8.495E-03 | BCL2, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 4.053E-04 | 8.495E-03 | BCL2, MAPK1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 5.216E-04 | 8.495E-03 | BCL2, MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 6.295E-04 | 8.495E-03 | BCL2, MAPK1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 5.424E-04 | 8.495E-03 | BCL2, MAPK1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05145 | Toxoplasmosis | 7.110E-04 | 8.495E-03 | BCL2, MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04722 | Neurotrophin signaling pathway | 7.351E-04 | 8.495E-03 | BCL2, MAPK1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 9.984E-04 | 9.661E-03 | BCL2, MAPK1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 1.085E-03 | 9.661E-03 | BCL2, MAPK1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 7.351E-04 | 8.495E-03 | BCL2, MAPK1 |
09150 Organismal Systems | 09153 Circulatory system | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.115E-03 | 9.661E-03 | BCL2, MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Hairy cell leukemia | C91.4 | ADA; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | ADA; |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Immunodeficiency | D84.9 | ADA; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Chronic pain | R52.1-R52.2, G89 | ADA; |